Locate providers:   

Juvederm XC Receives FDA Approval


Juvederm XC offers the same benefits without the pain, so go on, smile more.

juvederm xc

Today Allergan, the pharmaceutical company which manufactures Botox, announced the U.S. Food and Drug Administration's (FDA) approval of JUV?DERM? XC, a new formulation Juvederm which contains lidocaine to make the treatment of moderate to severe facial wrinkles and folds much more comfortable.

Juvederm has a smooth consistency gel which makes it easier to inject and provides a more natural looking result which lasts for up to a year. This new formulation of Juvederm maintains the same result and also contains 0.3% lidocaine, which numbs the treatment area within seconds. Hopefully, this will reduce the need for any additional anesthetic.

The FDA approval was based on clinical data in a multicenter, double-blind, randomized clinical trial in which patients received injections of Juvederm or Juvederm XC in each nasolabial fold. 93% of patients reported less pain when treated with the new formulation of Juvederm compared to those treated with the non-lidocaine formulation.

Juvederm XC is now available for ordering nationwide. Just like other Juvederm products, it must be administered by a trained medical professional.